ArticleEBioMedicine2024

Enhanced immune checkpoint inhibitor therapy for advanced recurrent cervical cancer: the key to treatment efficacy and maintenance of quality of life.

Masahiro Kagabu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.